Thomas Ciulla MD PC

Gene Therapy for Retinal Disease https://t.co/CDezBt3HxD via @YouTube Source by Thomas Ciulla, MD, MBA Return to main website.

Given recent clinical trial results in geographic atrophy/dry AMD, there has been great interest in our review of complement inhibition as a therapeutic strategy in retinal disorders #retina #eye #macula #AMD #clinicaltrials https://t.co/z4YaBgcE1n Source by Thomas Ciulla, MD, MBA Return to main website.

Interesting…The potential benefits of this approach have been noted across multiple species… Efficacy and safety of suprachoroidal triamcinolone injection in horses with poorly responsive equine recurrent uveitis https://t.co/ebK5fdMGew Source by Thomas Ciulla, MD, MBA Return to main website.

Just published…With ~50% patients not requiring additional treatment for 9 months after the last CLS-TA treatment, demonstrates the potential for durability with the suprachoroidal platform & small molecule suspensions such as CLS-TA. #retina #eyes https://t.co/JRiSW8r5ht Source by Thomas Ciulla, MD, MBA Return to main website.

Given recent clinical trial results, there has been great interest in our review of this pathway for the treatment of macular degeneration and diabetic macular edema …https://t.co/OaBS7cUlXs Source by Thomas Ciulla, MD, MBA Return to main website.

RT @ThomasCiullaMD: Just published: OCT plays a key role in retina care & clinical trials, but OCT biomarkers can show limited correlation… Source by Thomas Ciulla, MD, MBA Return to main website.

RT @ThomasCiullaMD: Honored to moderate this very interesting #genetherapy panel discussion, now available via podcast… OIS Podcast Episo… Source by Thomas Ciulla, MD, MBA Return to main website.